<?xml version="1.0" encoding="UTF-8"?>
<ref id="B79-vaccines-07-00074">
 <label>79.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Subbaraman</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Schanz</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Trkola</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy?</article-title>
  <source>Retrovirology</source>
  <year>2018</year>
  <volume>15</volume>
  <fpage>635</fpage>
  <pub-id pub-id-type="doi">10.1186/s12977-018-0433-2</pub-id>
 </element-citation>
</ref>
